Ropes Wealth Advisors LLC Clovis Oncology, Inc. Transaction History

Ropes Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$4.81 - $10.34 $9,408 - $20,225	-1,956 Closed	0 $0
Q3 2020 Oct 16, 2020	BUY	$4.82 - $7.72 $9,427 - $15,100	1,956 New	1,956 $11,000
Q3 2019 Nov 05, 2019	SELL	$3.93 - $15.35 $7,074 - $27,630	-1,800 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$12.81 - $25.67 $23,058 - $46,206	1,800 New	1,800 $27,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Ropes Wealth Advisors LLC with notifications on news.